The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · International

[2026 update] Availability by country, dated, with primary sources

MI
m.ibarraTL210 Dec 2025#1

On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion.

Documenting an access outcome, dated, because everything in this category expires.

As of March 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

23 likes 8mo
ST
s.teixeiraTL215 Dec 2025#2

I read the opening post twice before replying, because I had assumed the opposite.

Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.

This is the sort of thing that ought to be settled and apparently is not.

25 likes 7mo
RH
revision_historyTL3Wiki editor19 Dec 2025#3

Summarising the Availability thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.

0 likes 7mo
MI
m.ilungaTL223 Dec 2025#4
revision_history, post #3: Summarising the Availability thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length. Go to post

What I can speak to on Availability is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.

1 like in reply to #3 7mo
GV
g.valckenaereTL3Regular26 Dec 2025#5

Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly.

18 likes 7mo
AL
a.lindqvistTL229 Dec 2025#6

Adding a reference point for Availability. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.

0 likes 7mo
DN
desiccant_notesTL2Member1 Jan 2026#7

Post #6 answers the question as asked. The question underneath it is different.

Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.

I would hold that lightly until someone with a larger sample weighs in.

0 likes 7mo
SR
s.roosTL23 Jan 2026 · edited#8
a.lindqvist, post #6: Adding a reference point for Availability. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately. Go to post

Right — I had this wrong and I am glad to have read it before it mattered.

4 likes in reply to #6 7mo
L
LeitermanTL3Regular6 Jan 2026 · edited#9
m.ilunga, post #4: What I can speak to on Availability is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know. Go to post

This follows post #6 rather than contradicting it.

Reporting rather than recommending, on Availability. What happened is above. Whether it should have is a different question and not one I am qualified to answer.

4 likes in reply to #4 7mo
GE
g.ekstromTL29 Jan 2026#10

Checked the Availability claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.

13 likes 7mo
JF
j.fonsecaTL211 Jan 2026 · edited#11

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

0 likes 7mo
DO
dr_okonkwoTL4 Moderator14 Jan 2026#12

Post #11 is right about the mechanism and I think understates the practical bit.

The version of Availability that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.

24 likes 6mo
NB
n.brobergTL216 Jan 2026#13
m.ilunga, post #4: What I can speak to on Availability is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know. Go to post

I read post #11 twice before replying, because I had assumed the opposite.

A first-hand dated account for a region with thin coverage is worth more here than any summary, and the regions with thin coverage are most of them.

The answer changed when I changed how I was measuring, which was informative.

7 likes in reply to #4 6mo
PW
PharmNotes_WhitfieldTL4Pharmacist18 Jan 2026#14
m.ibarra, post #1: On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of March 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it,… Go to post

Thank you for taking the time. That was more work than a reply usually is.

1 like in reply to #1 6mo
PM
p.mwangiTL221 Jan 2026#15

On post #11 — agreed on the reasoning, with one qualification.

Reading this Availability thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.

0 likes 6mo
OO
orbitrap_olaTL3Mass spectrometrist23 Jan 2026#16

Post #15 answers the question as asked. The question underneath it is different.

Language matters for finding primary sources. The authoritative document is usually not in English and the translation usually is not authoritative.

That is one dataset and I would not build a rule on it.

17 likes 6mo
RF
ro.friskTL225 Jan 2026#17

Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.

I would be glad to be shown a cleaner way of putting this.

4 likes 6mo
DS
dr_seongTL328 Jan 2026#18
ZL
z.laurentTL230 Jan 2026#19

Worth separating two things that post #15 runs together.

Regional stock in your own country removes the border question entirely, which is the reason it changes the calculation rather than just the timing.

I would put the burden of proof on the interesting explanation, not the dull one.

25 likes 6mo
DY
d.yilmazTL21 Feb 2026#20

That is clearer than the version I had in my head. Thank you.

12 likes 6mo
AN
a.nwosuTL23 Feb 2026#21
m.ilunga, post #4: What I can speak to on Availability is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know. Go to post

Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.

The short answer was in the first line; everything after is the working.

31 likes in reply to #4 6mo
AB
a.batistaTL25 Feb 2026#22
Leiterman, post #9: This follows post #6 rather than contradicting it. Reporting rather than recommending, on Availability. What happened is above. Whether it should have is a different question and not one I am qualified to answer. Go to post

That matches what I have seen, for whatever a single anecdote is worth.

0 likes in reply to #9 6mo
AN
a.novakTL27 Feb 2026 · edited#23

Picking up post #21: that is the part I would want checked first.

Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and coverage is necessary.

3 likes 6mo
BN
bench_notesTL4 Moderator10 Feb 2026#24

Coming back to post #23, because the follow-up matters more than the original answer.

The question underneath Availability is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.

Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.

11 likes 6mo
EV
e.vargaTL212 Feb 2026#25

Useful. I have added it to my own notes with the date on it.

0 likes 5mo
RA
r.aldana_pharmdTL4Pharmacist14 Feb 2026#26
s.roos, post #8: Right — I had this wrong and I am glad to have read it before it mattered. Go to post

Availability, approval and reimbursement are three separate questions and a country can be in a different state on each.

The confident version of this sentence would be wrong, so here is the hedged one.

1 like in reply to #8 5mo
SO
s.okaforTL216 Feb 2026#27

Answering the Availability question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.

6 likes 5mo
LG
lc_gradientTL3Analytical chemist18 Feb 2026#28

I read post #26 twice before replying, because I had assumed the opposite.

Nobody has said the unglamorous part of Availability yet, so: most of the variation is explained by things that are boring to write about and easy to check.

16 likes 5mo
DV
d.vukovicTL220 Feb 2026#29

Regional stock in your own country removes the border question entirely, which is the reason it changes the calculation rather than just the timing.

17 likes 5mo
DB
dr_bhattacharyaTL3Physician22 Feb 2026#30
a.lindqvist, post #6: Adding a reference point for Availability. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately. Go to post

On post #26 — agreed on the reasoning, with one qualification.

Taking Availability seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two things support very different sentences.

32 likes in reply to #6 5mo